TERNS PHARMACEUTICALS INC (TERN)
US8808811074 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1M | -100.00% | 7.058M | 13.056M 84.98% | 30.822M 136.08% | 205.29M 566.05% | 366.63M 78.59% | 681.62M 85.91% | |||||||
| EBITDA YoY % growth | -70M -280.64% | -36.64M 47.66% | -49.35M -34.69% | -64.25M -24.72% | -104.478M -66.15% | -105.06M -2.73% | -128.52M -22.33% | -168.3M -30.95% | -147.492M 12.36% | -128.928M 12.59% | -105.774M 17.96% | 113.83M 207.62% | 153.1M 34.50% | 499.9M 226.52% | |
| EBIT YoY % growth | -70.2M -280.28% | -37.03M 47.25% | -49.86M -34.65% | -64.802M -24.41% | -135.246M -65.34% | -105.317M -2.69% | -126.479M -20.09% | -147.367M -16.52% | -155.091M -5.24% | -148.083M 4.52% | -136.959M 7.51% | -46.881M 65.77% | 27.904M 159.52% | 235.76M 744.90% | |
| Operating Margin | N/A | N/A | -4,986.00% | N/A | N/A | N/A | N/A | N/A | -2,197.38% | -1,134.21% | -444.36% | -22.84% | 7.61% | 34.59% | |
| EPS YoY % growth | N/A | N/A | -2.34 28.53% | -1.92 21.79% | -1.36 30.60% | -1.22 3.69% | -1.36 -11.19% | -1.52 -11.75% | -1.61 -6.04% | -1.37 14.87% | -0.86 37.05% | 0.04 104.72% | 0.72 1,675.00% | 2.29 216.20% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -6.52% | -0.34 -12.47% | -0.34 -11.21% | -0.35 -26.33% | -0.38 -22.17% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -27.54M -15.88% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.693M -15.11% | -29.531M -16.05% | -31.278M -22.48% | -33.936M -36.08% | -39.27M -41.80% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.28 33.33% | -0.33 | 0.05 | 14.33% |
| Q2 2024 Q2Q % growth | -0.31 -24.00% | -0.35 | 0.04 | 10.61% |
| Q1 2024 Q2Q % growth | -0.30 3.23% | -0.34 | 0.04 | 12.85% |
| Q4 2023 Q2Q % growth | -0.29 | -0.30 | 0.01 | 2.71% |
| Q3 2023 Q2Q % growth | -0.42 4.55% | -0.31 | -0.11 | -34.76% |
| Q2 2023 Q2Q % growth | -0.25 54.55% | -0.35 | 0.10 | 27.68% |
| Q1 2023 Q2Q % growth | -0.31 43.64% | -0.27 | -0.04 | -13.53% |
| Q4 2022 Q2Q % growth | -0.29 48.21% | -0.44 | 0.15 | 33.88% |
| Q3 2022 Q2Q % growth | -0.44 6.38% | -0.53 | 0.09 | 17.04% |
| Q2 2022 Q2Q % growth | -0.55 -27.91% | -0.61 | 0.06 | 9.12% |
| Q1 2022 Q2Q % growth | -0.55 37.50% | -0.66 | 0.11 | 16.18% |
| Q4 2021 Q2Q % growth | -0.56 98.19% | -0.64 | 0.08 | 12.39% |
| Q3 2021 Q2Q % growth | -0.47 | -0.62 | 0.15 | 23.63% |
| Q2 2021 Q2Q % growth | -0.43 | -0.72 | 0.29 | 40.62% |
| Q1 2021 Q2Q % growth | -0.88 | -0.79 | -0.09 | -11.56% |
| Q4 2020 Q2Q % growth | -30.94 | -0.93 | -30.01 | -3,233.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.82% | 0.19% | 6.52% |
| Revenue | N/A | -100% | N/A | N/A |